Reports

Industry Research Reports

Global Fully Automated Nucleic Acid Purification System Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Fully Automated Nucleic Acid Purification System Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Machinery & Equipment

Published Date: 2025-08-05

Pages: 182 Pages

Report ld: 4866107

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Fully Automated Nucleic Acid Purification System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

A Fully Automated Nucleic Acid Purification System is a laboratory instrument designed to streamline the process of extracting nucleic acids, such as DNA or RNA, from various biological samples (e.g., blood, tissues, cells). These systems automate multiple steps in the purification process, reducing manual labor, minimizing the risk of contamination, and improving reproducibility and throughput. They are widely used in molecular biology, clinical diagnostics, and research settings.

From a downstream perspective, Clinical Diagnostics accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Fully Automated Nucleic Acid Purification System leading manufacturers including Daan Gene, Promega Corporation, Analytik Jena GmbH+Co, BIOBASE Group, Aurora, Bioneer Corporation, TransGen Biotech Co., Ltd, QIAGEN, Hybribio, Sansure Biotech Inc, etc., dominate supply; the top five capture approximately % of global revenue, with Daan Gene leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Fully Automated Nucleic Acid Purification System market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Daan Gene
  • Promega Corporation
  • Analytik Jena GmbH+Co
  • BIOBASE Group
  • Aurora
  • Bioneer Corporation
  • TransGen Biotech Co., Ltd
  • QIAGEN
  • Hybribio
  • Sansure Biotech Inc
  • Zeesan Biotech
  • Lepu Medical Technology(Beijing)Co.,Ltd
  • Thermofisher Scientific
  • MGI Tech Co., Ltd
  • Xi'an Tianlong Science and Technology Co., Ltd
  • TIANGEN BIOTECH (BEIJING) CO.,LTD
  • novogene
  • CLONIT srl
  • F. Hoffmann-La Roche
  • Esco Micro Pte. Ltd
  • zinexts
  • GeneProof
  • Magen Biotechnology
  • ADS Biotec Inc
  • Wuxi Techstar Technology Co

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • High Throughput Systems
  • Medium Throughput Systems
  • Low Throughput Systems

Segment by Application

  • Clinical Diagnostics
  • Pharmaceutical Research
  • Forensic Science
  • Agricultural and Environmental Biotechnology
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Fully Automated Nucleic Acid Purification System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

marn_i1

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

marn_i1

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

marn_i1

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

marn_i1

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

marn_i1

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

marn_i1

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Fully Automated Nucleic Acid Purification System: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Fully Automated Nucleic Acid Purification System Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 High Throughput Systems

1.2.3 Medium Throughput Systems

1.2.4 Low Throughput Systems

1.3 Market Segmentation by Application

1.3.1 Global Fully Automated Nucleic Acid Purification System Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Clinical Diagnostics

1.3.3 Pharmaceutical Research

1.3.4 Forensic Science

1.3.5 Agricultural and Environmental Biotechnology

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Fully Automated Nucleic Acid Purification System Revenue Estimates and Forecasts 2020-2031

2.2 Global Fully Automated Nucleic Acid Purification System Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Fully Automated Nucleic Acid Purification System Sales Estimates and Forecasts 2020-2031

2.4 Global Fully Automated Nucleic Acid Purification System Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

muLu

3 Global Production Analysis

3.1 Global Fully Automated Nucleic Acid Purification System Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

muLu

4 Competition by Manufacturers

4.1 Global Fully Automated Nucleic Acid Purification System Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Fully Automated Nucleic Acid Purification System Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 High Throughput Systems Market Size by Manufacturers

4.5.2 Medium Throughput Systems Market Size by Manufacturers

4.5.3 Low Throughput Systems Market Size by Manufacturers

4.6 Global Fully Automated Nucleic Acid Purification System Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

5 Global Product Segmentation Analysis

5.1 Global Fully Automated Nucleic Acid Purification System Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Fully Automated Nucleic Acid Purification System Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

muLu

6 Global Downstream Application Analysis

6.1 Global Fully Automated Nucleic Acid Purification System Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Fully Automated Nucleic Acid Purification System Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

muLu

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Fully Automated Nucleic Acid Purification System Sales and Revenue by Type (2020-2031)

7.4 North America Fully Automated Nucleic Acid Purification System Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Fully Automated Nucleic Acid Purification System Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

muLu

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Fully Automated Nucleic Acid Purification System Sales and Revenue by Type (2020-2031)

8.4 Europe Fully Automated Nucleic Acid Purification System Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Fully Automated Nucleic Acid Purification System Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

muLu

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Fully Automated Nucleic Acid Purification System Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Fully Automated Nucleic Acid Purification System Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Fully Automated Nucleic Acid Purification System Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

muLu

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Fully Automated Nucleic Acid Purification System Sales and Revenue by Type (2020-2031)

10.4 Central and South America Fully Automated Nucleic Acid Purification System Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Fully Automated Nucleic Acid Purification System Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

muLu

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Fully Automated Nucleic Acid Purification System Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Fully Automated Nucleic Acid Purification System Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Fully Automated Nucleic Acid Purification System Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

muLu

12 Corporate Profile

12.1 Daan Gene

12.1.1 Daan Gene Corporation Information

12.1.2 Daan Gene Business Overview

12.1.3 Daan Gene Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.1.4 Daan Gene Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Daan Gene Fully Automated Nucleic Acid Purification System Sales by Product in 2024

12.1.6 Daan Gene Fully Automated Nucleic Acid Purification System Sales by Application in 2024

12.1.7 Daan Gene Fully Automated Nucleic Acid Purification System Sales by Geographic Area in 2024

12.1.8 Daan Gene Fully Automated Nucleic Acid Purification System SWOT Analysis

12.1.9 Daan Gene Recent Developments

12.2 Promega Corporation

12.2.1 Promega Corporation Corporation Information

12.2.2 Promega Corporation Business Overview

12.2.3 Promega Corporation Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.2.4 Promega Corporation Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Promega Corporation Fully Automated Nucleic Acid Purification System Sales by Product in 2024

12.2.6 Promega Corporation Fully Automated Nucleic Acid Purification System Sales by Application in 2024

12.2.7 Promega Corporation Fully Automated Nucleic Acid Purification System Sales by Geographic Area in 2024

12.2.8 Promega Corporation Fully Automated Nucleic Acid Purification System SWOT Analysis

12.2.9 Promega Corporation Recent Developments

12.3 Analytik Jena GmbH+Co

12.3.1 Analytik Jena GmbH+Co Corporation Information

12.3.2 Analytik Jena GmbH+Co Business Overview

12.3.3 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.3.4 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System Sales by Product in 2024

12.3.6 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System Sales by Application in 2024

12.3.7 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System Sales by Geographic Area in 2024

12.3.8 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System SWOT Analysis

12.3.9 Analytik Jena GmbH+Co Recent Developments

12.4 BIOBASE Group

12.4.1 BIOBASE Group Corporation Information

12.4.2 BIOBASE Group Business Overview

12.4.3 BIOBASE Group Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.4.4 BIOBASE Group Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 BIOBASE Group Fully Automated Nucleic Acid Purification System Sales by Product in 2024

12.4.6 BIOBASE Group Fully Automated Nucleic Acid Purification System Sales by Application in 2024

12.4.7 BIOBASE Group Fully Automated Nucleic Acid Purification System Sales by Geographic Area in 2024

12.4.8 BIOBASE Group Fully Automated Nucleic Acid Purification System SWOT Analysis

12.4.9 BIOBASE Group Recent Developments

12.5 Aurora

12.5.1 Aurora Corporation Information

12.5.2 Aurora Business Overview

12.5.3 Aurora Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.5.4 Aurora Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Aurora Fully Automated Nucleic Acid Purification System Sales by Product in 2024

12.5.6 Aurora Fully Automated Nucleic Acid Purification System Sales by Application in 2024

12.5.7 Aurora Fully Automated Nucleic Acid Purification System Sales by Geographic Area in 2024

12.5.8 Aurora Fully Automated Nucleic Acid Purification System SWOT Analysis

12.5.9 Aurora Recent Developments

12.6 Bioneer Corporation

12.6.1 Bioneer Corporation Corporation Information

12.6.2 Bioneer Corporation Business Overview

12.6.3 Bioneer Corporation Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.6.4 Bioneer Corporation Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Bioneer Corporation Recent Developments

12.7 TransGen Biotech Co., Ltd

12.7.1 TransGen Biotech Co., Ltd Corporation Information

12.7.2 TransGen Biotech Co., Ltd Business Overview

12.7.3 TransGen Biotech Co., Ltd Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.7.4 TransGen Biotech Co., Ltd Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 TransGen Biotech Co., Ltd Recent Developments

12.8 QIAGEN

12.8.1 QIAGEN Corporation Information

12.8.2 QIAGEN Business Overview

12.8.3 QIAGEN Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.8.4 QIAGEN Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 QIAGEN Recent Developments

12.9 Hybribio

12.9.1 Hybribio Corporation Information

12.9.2 Hybribio Business Overview

12.9.3 Hybribio Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.9.4 Hybribio Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Hybribio Recent Developments

12.10 Sansure Biotech Inc

12.10.1 Sansure Biotech Inc Corporation Information

12.10.2 Sansure Biotech Inc Business Overview

12.10.3 Sansure Biotech Inc Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.10.4 Sansure Biotech Inc Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Sansure Biotech Inc Recent Developments

12.11 Zeesan Biotech

12.11.1 Zeesan Biotech Corporation Information

12.11.2 Zeesan Biotech Business Overview

12.11.3 Zeesan Biotech Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.11.4 Zeesan Biotech Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 Zeesan Biotech Recent Developments

12.12 Lepu Medical Technology(Beijing)Co.,Ltd

12.12.1 Lepu Medical Technology(Beijing)Co.,Ltd Corporation Information

12.12.2 Lepu Medical Technology(Beijing)Co.,Ltd Business Overview

12.12.3 Lepu Medical Technology(Beijing)Co.,Ltd Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.12.4 Lepu Medical Technology(Beijing)Co.,Ltd Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.5 Lepu Medical Technology(Beijing)Co.,Ltd Recent Developments

12.13 Thermofisher Scientific

12.13.1 Thermofisher Scientific Corporation Information

12.13.2 Thermofisher Scientific Business Overview

12.13.3 Thermofisher Scientific Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.13.4 Thermofisher Scientific Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.5 Thermofisher Scientific Recent Developments

12.14 MGI Tech Co., Ltd

12.14.1 MGI Tech Co., Ltd Corporation Information

12.14.2 MGI Tech Co., Ltd Business Overview

12.14.3 MGI Tech Co., Ltd Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.14.4 MGI Tech Co., Ltd Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.14.5 MGI Tech Co., Ltd Recent Developments

12.15 Xi'an Tianlong Science and Technology Co., Ltd

12.15.1 Xi'an Tianlong Science and Technology Co., Ltd Corporation Information

12.15.2 Xi'an Tianlong Science and Technology Co., Ltd Business Overview

12.15.3 Xi'an Tianlong Science and Technology Co., Ltd Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.15.4 Xi'an Tianlong Science and Technology Co., Ltd Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.15.5 Xi'an Tianlong Science and Technology Co., Ltd Recent Developments

12.16 TIANGEN BIOTECH (BEIJING) CO.,LTD

12.16.1 TIANGEN BIOTECH (BEIJING) CO.,LTD Corporation Information

12.16.2 TIANGEN BIOTECH (BEIJING) CO.,LTD Business Overview

12.16.3 TIANGEN BIOTECH (BEIJING) CO.,LTD Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.16.4 TIANGEN BIOTECH (BEIJING) CO.,LTD Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.16.5 TIANGEN BIOTECH (BEIJING) CO.,LTD Recent Developments

12.17 novogene

12.17.1 novogene Corporation Information

12.17.2 novogene Business Overview

12.17.3 novogene Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.17.4 novogene Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.17.5 novogene Recent Developments

12.18 CLONIT srl

12.18.1 CLONIT srl Corporation Information

12.18.2 CLONIT srl Business Overview

12.18.3 CLONIT srl Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.18.4 CLONIT srl Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.18.5 CLONIT srl Recent Developments

12.19 F. Hoffmann-La Roche

12.19.1 F. Hoffmann-La Roche Corporation Information

12.19.2 F. Hoffmann-La Roche Business Overview

12.19.3 F. Hoffmann-La Roche Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.19.4 F. Hoffmann-La Roche Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.19.5 F. Hoffmann-La Roche Recent Developments

12.20 Esco Micro Pte. Ltd

12.20.1 Esco Micro Pte. Ltd Corporation Information

12.20.2 Esco Micro Pte. Ltd Business Overview

12.20.3 Esco Micro Pte. Ltd Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.20.4 Esco Micro Pte. Ltd Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.20.5 Esco Micro Pte. Ltd Recent Developments

12.21 zinexts

12.21.1 zinexts Corporation Information

12.21.2 zinexts Business Overview

12.21.3 zinexts Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.21.4 zinexts Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.21.5 zinexts Recent Developments

12.22 GeneProof

12.22.1 GeneProof Corporation Information

12.22.2 GeneProof Business Overview

12.22.3 GeneProof Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.22.4 GeneProof Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.22.5 GeneProof Recent Developments

12.23 Magen Biotechnology

12.23.1 Magen Biotechnology Corporation Information

12.23.2 Magen Biotechnology Business Overview

12.23.3 Magen Biotechnology Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.23.4 Magen Biotechnology Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.23.5 Magen Biotechnology Recent Developments

12.24 ADS Biotec Inc

12.24.1 ADS Biotec Inc Corporation Information

12.24.2 ADS Biotec Inc Business Overview

12.24.3 ADS Biotec Inc Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.24.4 ADS Biotec Inc Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.24.5 ADS Biotec Inc Recent Developments

12.25 Wuxi Techstar Technology Co

12.25.1 Wuxi Techstar Technology Co Corporation Information

12.25.2 Wuxi Techstar Technology Co Business Overview

12.25.3 Wuxi Techstar Technology Co Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications

12.25.4 Wuxi Techstar Technology Co Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.25.5 Wuxi Techstar Technology Co Recent Developments

muLu

13 Value Chain and Supply-Chain Analysis

13.1 Fully Automated Nucleic Acid Purification System Industry Chain

13.2 Fully Automated Nucleic Acid Purification System Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Fully Automated Nucleic Acid Purification System Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Fully Automated Nucleic Acid Purification System Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

muLu

14 Fully Automated Nucleic Acid Purification System Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

muLu

15 Key Findings in the Global Fully Automated Nucleic Acid Purification System Study

muLu

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Fully Automated Nucleic Acid Purification System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Fully Automated Nucleic Acid Purification System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Fully Automated Nucleic Acid Purification System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Fully Automated Nucleic Acid Purification System Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Fully Automated Nucleic Acid Purification System Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Fully Automated Nucleic Acid Purification System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Fully Automated Nucleic Acid Purification System Sales by Region (2020-2025) & (Units)
Table 8. Global Fully Automated Nucleic Acid Purification System Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Fully Automated Nucleic Acid Purification System Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 11. Global Fully Automated Nucleic Acid Purification System Production by Region (2020-2025) & (Units)
Table 12. Global Fully Automated Nucleic Acid Purification System Production by Region (2026-2031) & (Units)
Table 13. Global Fully Automated Nucleic Acid Purification System Sales by Manufacturers (2020-2025) & (Units)
Table 14. Global Fully Automated Nucleic Acid Purification System Sales Share by Manufacturers (2020-2025)
Table 15. Global Fully Automated Nucleic Acid Purification System Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Fully Automated Nucleic Acid Purification System Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Fully Automated Nucleic Acid Purification System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fully Automated Nucleic Acid Purification System as of 2024)
Table 19. Global Fully Automated Nucleic Acid Purification System Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Fully Automated Nucleic Acid Purification System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Fully Automated Nucleic Acid Purification System Manufacturing Base and Headquarters
Table 22. Global Fully Automated Nucleic Acid Purification System Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Fully Automated Nucleic Acid Purification System Sales by Type (2020-2025) & (Units)
Table 26. Global Fully Automated Nucleic Acid Purification System Sales by Type (2026-2031) & (Units)
Table 27. Global Fully Automated Nucleic Acid Purification System Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Fully Automated Nucleic Acid Purification System Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Fully Automated Nucleic Acid Purification System ASP by Type (2020-2031) & (US$/Unit)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Fully Automated Nucleic Acid Purification System Sales by Application (2020-2025) & (Units)
Table 32. Global Fully Automated Nucleic Acid Purification System Sales by Application (2026-2031) & (Units)
Table 33. Fully Automated Nucleic Acid Purification System High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Fully Automated Nucleic Acid Purification System Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Fully Automated Nucleic Acid Purification System Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Fully Automated Nucleic Acid Purification System ASP by Application (2020-2031) & (US$/Unit)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Fully Automated Nucleic Acid Purification System Growth Accelerators and Market Barriers
Table 40. North America Fully Automated Nucleic Acid Purification System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Fully Automated Nucleic Acid Purification System Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Fully Automated Nucleic Acid Purification System Growth Accelerators and Market Barriers
Table 43. Europe Fully Automated Nucleic Acid Purification System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Fully Automated Nucleic Acid Purification System Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Fully Automated Nucleic Acid Purification System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Fully Automated Nucleic Acid Purification System Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Fully Automated Nucleic Acid Purification System Growth Accelerators and Market Barriers
Table 48. Southeast Asia Fully Automated Nucleic Acid Purification System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Fully Automated Nucleic Acid Purification System Investment Opportunities and Key Challenges
Table 50. Central and South America Fully Automated Nucleic Acid Purification System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Fully Automated Nucleic Acid Purification System Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Fully Automated Nucleic Acid Purification System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Daan Gene Corporation Information
Table 54. Daan Gene Description and Major Businesses
Table 55. Daan Gene Product Models, Descriptions and Specifications
Table 56. Daan Gene Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 57. Daan Gene Sales Value Proportion by Product in 2024
Table 58. Daan Gene Sales Value Proportion by Application in 2024
Table 59. Daan Gene Sales Value Proportion by Geographic Area in 2024
Table 60. Daan Gene Fully Automated Nucleic Acid Purification System SWOT Analysis
Table 61. Daan Gene Recent Developments
Table 62. Promega Corporation Corporation Information
Table 63. Promega Corporation Description and Major Businesses
Table 64. Promega Corporation Product Models, Descriptions and Specifications
Table 65. Promega Corporation Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 66. Promega Corporation Sales Value Proportion by Product in 2024
Table 67. Promega Corporation Sales Value Proportion by Application in 2024
Table 68. Promega Corporation Sales Value Proportion by Geographic Area in 2024
Table 69. Promega Corporation Fully Automated Nucleic Acid Purification System SWOT Analysis
Table 70. Promega Corporation Recent Developments
Table 71. Analytik Jena GmbH+Co Corporation Information
Table 72. Analytik Jena GmbH+Co Description and Major Businesses
Table 73. Analytik Jena GmbH+Co Product Models, Descriptions and Specifications
Table 74. Analytik Jena GmbH+Co Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Analytik Jena GmbH+Co Sales Value Proportion by Product in 2024
Table 76. Analytik Jena GmbH+Co Sales Value Proportion by Application in 2024
Table 77. Analytik Jena GmbH+Co Sales Value Proportion by Geographic Area in 2024
Table 78. Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System SWOT Analysis
Table 79. Analytik Jena GmbH+Co Recent Developments
Table 80. BIOBASE Group Corporation Information
Table 81. BIOBASE Group Description and Major Businesses
Table 82. BIOBASE Group Product Models, Descriptions and Specifications
Table 83. BIOBASE Group Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. BIOBASE Group Sales Value Proportion by Product in 2024
Table 85. BIOBASE Group Sales Value Proportion by Application in 2024
Table 86. BIOBASE Group Sales Value Proportion by Geographic Area in 2024
Table 87. BIOBASE Group Fully Automated Nucleic Acid Purification System SWOT Analysis
Table 88. BIOBASE Group Recent Developments
Table 89. Aurora Corporation Information
Table 90. Aurora Description and Major Businesses
Table 91. Aurora Product Models, Descriptions and Specifications
Table 92. Aurora Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Aurora Sales Value Proportion by Product in 2024
Table 94. Aurora Sales Value Proportion by Application in 2024
Table 95. Aurora Sales Value Proportion by Geographic Area in 2024
Table 96. Aurora Fully Automated Nucleic Acid Purification System SWOT Analysis
Table 97. Aurora Recent Developments
Table 98. Bioneer Corporation Corporation Information
Table 99. Bioneer Corporation Description and Major Businesses
Table 100. Bioneer Corporation Product Models, Descriptions and Specifications
Table 101. Bioneer Corporation Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. Bioneer Corporation Recent Developments
Table 103. TransGen Biotech Co., Ltd Corporation Information
Table 104. TransGen Biotech Co., Ltd Description and Major Businesses
Table 105. TransGen Biotech Co., Ltd Product Models, Descriptions and Specifications
Table 106. TransGen Biotech Co., Ltd Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. TransGen Biotech Co., Ltd Recent Developments
Table 108. QIAGEN Corporation Information
Table 109. QIAGEN Description and Major Businesses
Table 110. QIAGEN Product Models, Descriptions and Specifications
Table 111. QIAGEN Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. QIAGEN Recent Developments
Table 113. Hybribio Corporation Information
Table 114. Hybribio Description and Major Businesses
Table 115. Hybribio Product Models, Descriptions and Specifications
Table 116. Hybribio Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 117. Hybribio Recent Developments
Table 118. Sansure Biotech Inc Corporation Information
Table 119. Sansure Biotech Inc Description and Major Businesses
Table 120. Sansure Biotech Inc Product Models, Descriptions and Specifications
Table 121. Sansure Biotech Inc Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 122. Sansure Biotech Inc Recent Developments
Table 123. Zeesan Biotech Corporation Information
Table 124. Zeesan Biotech Description and Major Businesses
Table 125. Zeesan Biotech Product Models, Descriptions and Specifications
Table 126. Zeesan Biotech Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 127. Zeesan Biotech Recent Developments
Table 128. Lepu Medical Technology(Beijing)Co.,Ltd Corporation Information
Table 129. Lepu Medical Technology(Beijing)Co.,Ltd Description and Major Businesses
Table 130. Lepu Medical Technology(Beijing)Co.,Ltd Product Models, Descriptions and Specifications
Table 131. Lepu Medical Technology(Beijing)Co.,Ltd Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 132. Lepu Medical Technology(Beijing)Co.,Ltd Recent Developments
Table 133. Thermofisher Scientific Corporation Information
Table 134. Thermofisher Scientific Description and Major Businesses
Table 135. Thermofisher Scientific Product Models, Descriptions and Specifications
Table 136. Thermofisher Scientific Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 137. Thermofisher Scientific Recent Developments
Table 138. MGI Tech Co., Ltd Corporation Information
Table 139. MGI Tech Co., Ltd Description and Major Businesses
Table 140. MGI Tech Co., Ltd Product Models, Descriptions and Specifications
Table 141. MGI Tech Co., Ltd Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 142. MGI Tech Co., Ltd Recent Developments
Table 143. Xi'an Tianlong Science and Technology Co., Ltd Corporation Information
Table 144. Xi'an Tianlong Science and Technology Co., Ltd Description and Major Businesses
Table 145. Xi'an Tianlong Science and Technology Co., Ltd Product Models, Descriptions and Specifications
Table 146. Xi'an Tianlong Science and Technology Co., Ltd Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 147. Xi'an Tianlong Science and Technology Co., Ltd Recent Developments
Table 148. TIANGEN BIOTECH (BEIJING) CO.,LTD Corporation Information
Table 149. TIANGEN BIOTECH (BEIJING) CO.,LTD Description and Major Businesses
Table 150. TIANGEN BIOTECH (BEIJING) CO.,LTD Product Models, Descriptions and Specifications
Table 151. TIANGEN BIOTECH (BEIJING) CO.,LTD Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 152. TIANGEN BIOTECH (BEIJING) CO.,LTD Recent Developments
Table 153. novogene Corporation Information
Table 154. novogene Description and Major Businesses
Table 155. novogene Product Models, Descriptions and Specifications
Table 156. novogene Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 157. novogene Recent Developments
Table 158. CLONIT srl Corporation Information
Table 159. CLONIT srl Description and Major Businesses
Table 160. CLONIT srl Product Models, Descriptions and Specifications
Table 161. CLONIT srl Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 162. CLONIT srl Recent Developments
Table 163. F. Hoffmann-La Roche Corporation Information
Table 164. F. Hoffmann-La Roche Description and Major Businesses
Table 165. F. Hoffmann-La Roche Product Models, Descriptions and Specifications
Table 166. F. Hoffmann-La Roche Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 167. F. Hoffmann-La Roche Recent Developments
Table 168. Esco Micro Pte. Ltd Corporation Information
Table 169. Esco Micro Pte. Ltd Description and Major Businesses
Table 170. Esco Micro Pte. Ltd Product Models, Descriptions and Specifications
Table 171. Esco Micro Pte. Ltd Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 172. Esco Micro Pte. Ltd Recent Developments
Table 173. zinexts Corporation Information
Table 174. zinexts Description and Major Businesses
Table 175. zinexts Product Models, Descriptions and Specifications
Table 176. zinexts Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 177. zinexts Recent Developments
Table 178. GeneProof Corporation Information
Table 179. GeneProof Description and Major Businesses
Table 180. GeneProof Product Models, Descriptions and Specifications
Table 181. GeneProof Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 182. GeneProof Recent Developments
Table 183. Magen Biotechnology Corporation Information
Table 184. Magen Biotechnology Description and Major Businesses
Table 185. Magen Biotechnology Product Models, Descriptions and Specifications
Table 186. Magen Biotechnology Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 187. Magen Biotechnology Recent Developments
Table 188. ADS Biotec Inc Corporation Information
Table 189. ADS Biotec Inc Description and Major Businesses
Table 190. ADS Biotec Inc Product Models, Descriptions and Specifications
Table 191. ADS Biotec Inc Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 192. ADS Biotec Inc Recent Developments
Table 193. Wuxi Techstar Technology Co Corporation Information
Table 194. Wuxi Techstar Technology Co Description and Major Businesses
Table 195. Wuxi Techstar Technology Co Product Models, Descriptions and Specifications
Table 196. Wuxi Techstar Technology Co Capacity, Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 197. Wuxi Techstar Technology Co Recent Developments
Table 198. Key Raw Materials Distribution
Table 199. Raw Materials Key Suppliers
Table 200. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 201. Milestones in Production Technology Evolution
Table 202. Distributors List
Table 203. Market Trends and Market Evolution
Table 204. Market Drivers and Opportunities
Table 205. Market Challenges, Risks, and Restraints
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Fully Automated Nucleic Acid Purification System Product Picture
Figure 2. Global Fully Automated Nucleic Acid Purification System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. High Throughput Systems Product Picture
Figure 4. Medium Throughput Systems Product Picture
Figure 5. Low Throughput Systems Product Picture
Figure 6. Global Fully Automated Nucleic Acid Purification System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Clinical Diagnostics
Figure 8. Pharmaceutical Research
Figure 9. Forensic Science
Figure 10. Agricultural and Environmental Biotechnology
Figure 11. Others
Figure 12. Fully Automated Nucleic Acid Purification System Report Years Considered
Figure 13. Global Fully Automated Nucleic Acid Purification System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 15. Global Fully Automated Nucleic Acid Purification System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Fully Automated Nucleic Acid Purification System Revenue Market Share by Region (2020-2031)
Figure 17. Global Fully Automated Nucleic Acid Purification System Sales (2020-2031) & (Units)
Figure 18. Global Fully Automated Nucleic Acid Purification System Sales (CAGR) by Region (2020-2031) (Units)
Figure 19. Global Fully Automated Nucleic Acid Purification System Sales Market Share by Region (2020-2031)
Figure 20. Global Fully Automated Nucleic Acid Purification System Capacity, Production and Utilization (2020-2031) & (Units)
Figure 21. Global Fully Automated Nucleic Acid Purification System Production Trend by Region (2020-2031) (Units)
Figure 22. Global Fully Automated Nucleic Acid Purification System Production Market Share by Region (2020-2031)
Figure 23. Production Capacity Enablers & Constraints
Figure 24. Fully Automated Nucleic Acid Purification System Production Growth Rate in North America (2020-2031) & (Units)
Figure 25. Fully Automated Nucleic Acid Purification System Production Growth Rate in Europe (2020-2031) & (Units)
Figure 26. Fully Automated Nucleic Acid Purification System Production Growth Rate in China (2020-2031) & (Units)
Figure 27. Fully Automated Nucleic Acid Purification System Production Growth Rate in Japan (2020-2031) & (Units)
Figure 28. Top 5 and Top 10 Manufacturers Fully Automated Nucleic Acid Purification System Sales Volume Market Share in 2024
Figure 29. Global Fully Automated Nucleic Acid Purification System Revenue Market Share Ranking (2024)
Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 31. High Throughput Systems Revenue Market Share by Manufacturer in 2024
Figure 32. Medium Throughput Systems Revenue Market Share by Manufacturer in 2024
Figure 33. Low Throughput Systems Revenue Market Share by Manufacturer in 2024
Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 36. Global Fully Automated Nucleic Acid Purification System Sales Market Share by Type (2020-2031)
Figure 37. Global Fully Automated Nucleic Acid Purification System Revenue Market Share by Type (2020-2031)
Figure 38. Global Fully Automated Nucleic Acid Purification System Sales Market Share by Application (2020-2031)
Figure 39. Global Fully Automated Nucleic Acid Purification System Revenue Market Share by Application (2020-2031)
Figure 40. North America Fully Automated Nucleic Acid Purification System Sales YoY (2020-2031) & (Units)
Figure 41. North America Fully Automated Nucleic Acid Purification System Revenue YoY (2020-2031) & (US$ Million)
Figure 42. North America Top 5 Manufacturers Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) in 2024
Figure 43. North America Fully Automated Nucleic Acid Purification System Sales Volume (Units) by Type (2020- 2031)
Figure 44. North America Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 45. North America Fully Automated Nucleic Acid Purification System Sales Volume (Units) by Application (2020-2031)
Figure 46. North America Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. US Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 48. Canada Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 49. Mexico Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 50. Europe Fully Automated Nucleic Acid Purification System Sales YoY (2020-2031) & (Units)
Figure 51. Europe Fully Automated Nucleic Acid Purification System Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Europe Top 5 Manufacturers Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) in 2024
Figure 53. Europe Fully Automated Nucleic Acid Purification System Sales Volume (Units) by Type (2020-2031)
Figure 54. Europe Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 55. Europe Fully Automated Nucleic Acid Purification System Sales Volume (Units) by Application (2020-2031)
Figure 56. Europe Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Germany Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 58. France Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 59. U.K. Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 60. Italy Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 61. Russia Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Fully Automated Nucleic Acid Purification System Sales YoY (2020-2031) & (Units)
Figure 63. Asia-Pacific Fully Automated Nucleic Acid Purification System Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Asia-Pacific Top 8 Manufacturers Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) in 2024
Figure 65. Asia-Pacific Fully Automated Nucleic Acid Purification System Sales Volume (Units) by Type (2020- 2031)
Figure 66. Asia-Pacific Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 67. Asia-Pacific Fully Automated Nucleic Acid Purification System Sales Volume (Units) by Application (2020-2031)
Figure 68. Asia-Pacific Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Indonesia Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 70. Japan Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 71. South Korea Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 72. China Taiwan Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 73. India Fully Automated Nucleic Acid Purification System Revenue (2020-2031) & (US$ Million)
Figure 74. Central and South America Fully Automated Nucleic Acid Purification System Sales YoY (2020-2031) & (Units)
Figure 75. Central and South America Fully Automated Nucleic Acid Purification System Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Central and South America Top 5 Manufacturers Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) in 2024
Figure 77. Central and South America Fully Automated Nucleic Acid Purification System Sales Volume (Units) by Type (2021-2031)
Figure 78. Central and South America Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Central and South America Fully Automated Nucleic Acid Purification System Sales Volume (Units) by Application (2020-2031)
Figure 80. Central and South America Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. Brazil Fully Automated Nucleic Acid Purification System Revenue (2020-2025) & (US$ Million)
Figure 82. Argentina Fully Automated Nucleic Acid Purification System Revenue (2020-2025) & (US$ Million)
Figure 83. Middle East, and Africa Fully Automated Nucleic Acid Purification System Sales YoY (2020-2031) & (Units)
Figure 84. Middle East and Africa Fully Automated Nucleic Acid Purification System Revenue YoY (2020-2031) & (US$ Million)
Figure 85. Middle East and Africa Top 5 Manufacturers Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) in 2024
Figure 86. Middle East and Africa Fully Automated Nucleic Acid Purification System Sales Volume (Units) by Type (2021-2031)
Figure 87. South America Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 88. Middle East and Africa Fully Automated Nucleic Acid Purification System Sales Volume (Units) by Application (2020-2031)
Figure 89. Middle East and Africa Fully Automated Nucleic Acid Purification System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 90. GCC Countries Fully Automated Nucleic Acid Purification System Revenue (2020-2025) & (US$ Million)
Figure 91. Turkey Fully Automated Nucleic Acid Purification System Revenue (2020-2025) & (US$ Million)
Figure 92. Egypt Fully Automated Nucleic Acid Purification System Revenue (2020-2025) & (US$ Million)
Figure 93. South Africa Fully Automated Nucleic Acid Purification System Revenue (2020-2025) & (US$ Million)
Figure 94. Fully Automated Nucleic Acid Purification System Industry Chain Mapping
Figure 95. Regional Fully Automated Nucleic Acid Purification System Manufacturing Base Distribution (%)
Figure 96. Fully Automated Nucleic Acid Purification System Production Process
Figure 97. Regional Fully Automated Nucleic Acid Purification System Production Cost Structure
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Fully Automated Nucleic Acid Purification System market?zhanKai
The top companies in the global Fully Automated Nucleic Acid Purification System market are Daan Gene、Promega Corporation、Analytik Jena GmbH+Co.
den_biaoTiZhungShi

Related Reports

Global Fully Automated Nucleic Acid Purification System Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Machinery & Equipment

Published Date: 2025-08-05

Pages: 182 Pages

Report ld: 4866107

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now